MedPath

Seoul National University Hospital

Seoul National University Hospital logo
🇰🇷South Korea
Ownership
Private
Established
2003-01-01
Employees
501
Market Cap
-
Website
https://www.snubh.org

ProSeal Laryngeal Mask Airway (LMA) Size 3 vs 4 in Non-paralyzed Female Patients

Not Applicable
Completed
Conditions
Oropharyngeal Injury
Interventions
Device: insertion of the PLMA
Device: insertion of the ProSeal LMA (PLMA)
First Posted Date
2010-08-19
Last Posted Date
2012-08-27
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
154
Registration Number
NCT01184677
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

Study to Compare the Effect of Vytorin (Simvastatin/Ezetimibe) 10/20mg Versus Atorvastatin 20mg on ApoB/ApoA1 Ratio in Subjects With Diabetes

Phase 4
Conditions
Type 2 Diabetes Mellitus Without Insulin Treatment
Interventions
Drug: simvastatin/ezetimibe
First Posted Date
2010-08-19
Last Posted Date
2010-08-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
132
Registration Number
NCT01185236
Locations
🇰🇷

Seoul national university hospital, Seoul, Korea, Republic of

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

Phase 2
Conditions
Non-Hodgkin Lymphoma
Interventions
Drug: Busulfan, etoposide, cytarabine, and melphalan
First Posted Date
2010-08-10
Last Posted Date
2014-08-25
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
42
Registration Number
NCT01178645
Locations
🇰🇷

Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea, Republic of

🇰🇷

Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea, Republic of

and more 2 locations

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma

Phase 2
Conditions
Non-Hodgkin Lymphoma
Interventions
Drug: Busulfan, etoposide, cytarabine, and melphalan
First Posted Date
2010-08-10
Last Posted Date
2014-08-25
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
42
Registration Number
NCT01178658
Locations
🇰🇷

Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

🇰🇷

Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea, Republic of

🇰🇷

Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

and more 2 locations

A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.

Phase 4
Completed
Conditions
Chronic Kidney Disease
Interventions
First Posted Date
2010-07-30
Last Posted Date
2010-12-29
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
80
Registration Number
NCT01173107
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma

Phase 2
Terminated
Conditions
Carcinoma, Hepatocellular
Interventions
First Posted Date
2010-07-28
Last Posted Date
2017-04-26
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
5
Registration Number
NCT01171482
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Use of an Oxidized Regenerated Cellulose After Thyroid Surgery: A Prospective, Randomized Study

Not Applicable
Completed
Conditions
Thyroidectomy
Interventions
Device: application of oxidized regenerated cellulose
First Posted Date
2010-07-28
Last Posted Date
2010-07-28
Lead Sponsor
Seoul National University Hospital
Registration Number
NCT01171079
Locations
🇰🇷

Seoul National University College of Medicine, Seoul, Korea, Republic of

Comprehensive Analyses of Multidetector-row Cardiac Computed Tomography Data in Koreans

Completed
Conditions
Coronary Disease
First Posted Date
2010-07-27
Last Posted Date
2014-07-09
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
15000
Registration Number
NCT01170403
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Bundang-gu, Korea, Republic of

Korea Atherosclerosis Study-3

Completed
Conditions
Cardiovascular Diseases
Cardiovascular Mortality
All-cause Mortality
First Posted Date
2010-07-23
Last Posted Date
2013-10-25
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
4000
Registration Number
NCT01168362
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults

Not Applicable
Conditions
Healthy
Overweight
Obesity
First Posted Date
2010-07-22
Last Posted Date
2010-07-22
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
30
Registration Number
NCT01167205
Locations
🇰🇷

Clinical Research Institute Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath